368 related articles for article (PubMed ID: 10783930)
1. Direct medical costs of chronic obstructive pulmonary disease: chronic bronchitis and emphysema.
Wilson L; Devine EB; So K
Respir Med; 2000 Mar; 94(3):204-13. PubMed ID: 10783930
[TBL] [Abstract][Full Text] [Related]
2. Cost analysis of chronic obstructive pulmonary disease in a tertiary care setting in Taiwan.
Chiang CH
Respirology; 2008 Sep; 13(5):689-94. PubMed ID: 18513247
[TBL] [Abstract][Full Text] [Related]
3. Cost impact of COPD in Japan: opportunities and challenges?
Nishimura S; Zaher C
Respirology; 2004 Nov; 9(4):466-73. PubMed ID: 15612957
[TBL] [Abstract][Full Text] [Related]
4. Cost of illness of chronic angina.
Javitz HS; Ward MM; Watson JB; Jaana M
Am J Manag Care; 2004 Oct; 10(11 Suppl):S358-69. PubMed ID: 15603245
[TBL] [Abstract][Full Text] [Related]
5. Treatment cost of acute exacerbations of chronic bronchitis.
Niederman MS; McCombs JS; Unger AN; Kumar A; Popovian R
Clin Ther; 1999 Mar; 21(3):576-91. PubMed ID: 10321424
[TBL] [Abstract][Full Text] [Related]
6. Economic costs of diabetes in the U.S. In 2007.
American Diabetes Association
Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
[TBL] [Abstract][Full Text] [Related]
7. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
Jahnz-Rózyk K; Targowski T; From S
Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
[TBL] [Abstract][Full Text] [Related]
8. Direct medical cost of chronic obstructive pulmonary disease in the U.S.A.
Ward MM; Javitz HS; Smith WM; Bakst A
Respir Med; 2000 Nov; 94(11):1123-9. PubMed ID: 11127502
[TBL] [Abstract][Full Text] [Related]
9. The economic burden of smoking in California.
Max W; Rice DP; Sung HY; Zhang X; Miller L
Tob Control; 2004 Sep; 13(3):264-7. PubMed ID: 15333882
[TBL] [Abstract][Full Text] [Related]
10. Utilization and costs for children who have special health care needs and are enrolled in a hospital-based comprehensive primary care clinic.
Berman S; Rannie M; Moore L; Elias E; Dryer LJ; Jones MD
Pediatrics; 2005 Jun; 115(6):e637-42. PubMed ID: 15930189
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology and global impact of chronic obstructive pulmonary disease.
Mannino DM
Semin Respir Crit Care Med; 2005 Apr; 26(2):204-10. PubMed ID: 16088437
[TBL] [Abstract][Full Text] [Related]
12. Resource utilization in home health chronic obstructive pulmonary disease management.
Steinel JA; Madigan EA
Outcomes Manag; 2003; 7(1):23-7. PubMed ID: 12593122
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of outpatient and inpatient costs of moderate and severe exacerbations of chronic obstructive pulmonary disease in Poland].
Jahnz-Rózyk K; Targowski T; From S
Pneumonol Alergol Pol; 2008; 76(6):426-31. PubMed ID: 19173191
[TBL] [Abstract][Full Text] [Related]
14. An economic evaluation of asthma in the United States.
Weiss KB; Gergen PJ; Hodgson TA
N Engl J Med; 1992 Mar; 326(13):862-6. PubMed ID: 1542323
[TBL] [Abstract][Full Text] [Related]
15. The economic impact of asthma and chronic obstructive pulmonary disease (COPD) in Sweden in 1980 and 1991.
Jacobson L; Hertzman P; Löfdahl CG; Skoogh BE; Lindgren B
Respir Med; 2000 Mar; 94(3):247-55. PubMed ID: 10783936
[TBL] [Abstract][Full Text] [Related]
16. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
17. The economic costs of overactive bladder in Germany.
Klotz T; Brüggenjürgen B; Burkart M; Resch A
Eur Urol; 2007 Jun; 51(6):1654-62; discussion 1662-3. PubMed ID: 17161521
[TBL] [Abstract][Full Text] [Related]
18. Medical care expenditures and earnings losses of persons with arthritis and other rheumatic conditions in the United States in 1997: total and incremental estimates.
Yelin E; Cisternas MG; Pasta DJ; Trupin L; Murphy L; Helmick CG
Arthritis Rheum; 2004 Jul; 50(7):2317-26. PubMed ID: 15248233
[TBL] [Abstract][Full Text] [Related]
19. The excess cost of acute exacerbations of chronic bronchitis in patients aged 45 and older in England and Wales.
McGuire A; Irwin DE; Fenn P; Gray A; Anderson P; Lovering A; MacGowan A
Value Health; 2001; 4(5):370-5. PubMed ID: 11705127
[TBL] [Abstract][Full Text] [Related]
20. Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity.
Barsky AJ; Orav EJ; Bates DW
Arch Gen Psychiatry; 2005 Aug; 62(8):903-10. PubMed ID: 16061768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
